Open for inclusion

An Open-Label, Multicohort, Phase II study of Atezolizumab in Advanced Solid Tumors

Cancer type: Multiple diagnosis, Solide tumores

Phase: II

Principal Investigator: Bjørge Line

Country: NO

Keywords: Norway, Bergen, Solid Tumors

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02458638